Research advances in the mutation of TET2 gene in myeloid maligancies

Rong Li, Ming Jiang Xu, Feng Chun Yang, Yuan Zhou

Research output: Contribution to journalReview articlepeer-review


TET2 gene is a member of TET oncogene family. It has been reported as a tumor suppressor gene with important roles in myelopiesis. Recent studies have shown that TET2 protein takes part in demethylation by converting 5-methylcytosine (5-mc) into 5-hydroxymethylcytosine (5-hmc). Somatic TET2 inactivation leads to abnormal myelopiesis and myeloid malignancies. In this review, the structure and function of TET2 and the relationship between TET gene mutation and myeloid malignancies are summarized.

Original languageEnglish (US)
Pages (from-to)583-588
Number of pages6
JournalActa Academiae Medicinae Sinicae
Issue number5
StatePublished - Oct 30 2016
Externally publishedYes


  • Mutation
  • Myeloid malignancies
  • TET2

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Research advances in the mutation of TET2 gene in myeloid maligancies'. Together they form a unique fingerprint.

Cite this